S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
How major US stock indexes fared Thursday, 4/18/2024
Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed! (Ad)
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
The "Smart Money" Is Ready for May 1st Are You? (Ad)
Bear Market Funds to Watch This Year
Shares of Walmart-backed Ibotta soar on public debut
The A.I. story nobody is telling you (Read ASAP) (Ad)
Closing prices for crude oil, gold and other commodities
IMF's Georgieva says there's 'plenty to worry about' despite recovery for many economies
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
How major US stock indexes fared Thursday, 4/18/2024
Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed! (Ad)
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
The "Smart Money" Is Ready for May 1st Are You? (Ad)
Bear Market Funds to Watch This Year
Shares of Walmart-backed Ibotta soar on public debut
The A.I. story nobody is telling you (Read ASAP) (Ad)
Closing prices for crude oil, gold and other commodities
IMF's Georgieva says there's 'plenty to worry about' despite recovery for many economies
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
How major US stock indexes fared Thursday, 4/18/2024
Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed! (Ad)
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
The "Smart Money" Is Ready for May 1st Are You? (Ad)
Bear Market Funds to Watch This Year
Shares of Walmart-backed Ibotta soar on public debut
The A.I. story nobody is telling you (Read ASAP) (Ad)
Closing prices for crude oil, gold and other commodities
IMF's Georgieva says there's 'plenty to worry about' despite recovery for many economies
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
How major US stock indexes fared Thursday, 4/18/2024
Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed! (Ad)
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
The "Smart Money" Is Ready for May 1st Are You? (Ad)
Bear Market Funds to Watch This Year
Shares of Walmart-backed Ibotta soar on public debut
The A.I. story nobody is telling you (Read ASAP) (Ad)
Closing prices for crude oil, gold and other commodities
IMF's Georgieva says there's 'plenty to worry about' despite recovery for many economies
Free Trial

Kezar Life Sciences (KZR) News Today

→ New crypto project uncovers 2,050% in 65 days (From InvestorPlace) (Ad)
Free KZR Stock Alerts
$0.79
-0.03 (-3.67%)
(As of 04/18/2024 ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaSustainability
SourceHeadline
MarketBeat logoKezar Life Sciences, Inc. (NASDAQ:KZR) Short Interest Up 5.6% in March
americanbankingnews.com - April 16 at 1:26 AM
marketbeat.com logoKezar Life Sciences (NASDAQ:KZR) Trading Down 6.2%
marketbeat.com - April 16 at 12:43 AM
MarketBeat logoCentessa Pharmaceuticals (NASDAQ:CNTA) vs. Kezar Life Sciences (NASDAQ:KZR) Financial Survey
americanbankingnews.com - April 9 at 1:52 AM
businesswire.com logoKezar Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
businesswire.com - April 8 at 4:01 PM
investorplace.com logoFrom Pennies to Fortunes: 3 Stocks Set to Make Millionaires
investorplace.com - March 27 at 4:30 PM
marketbeat.com logoHC Wainwright Reaffirms Buy Rating for Kezar Life Sciences (NASDAQ:KZR)
marketbeat.com - March 18 at 6:43 PM
marketbeat.com logoKezar Life Sciences, Inc. (NASDAQ:KZR) Short Interest Up 6.0% in February
marketbeat.com - March 18 at 11:22 AM
investorplace.com logoDiamonds in the Dust: 3 Penny Stocks Set to Soar 500% by 2026
investorplace.com - March 16 at 6:56 AM
investorplace.com logoKZR Stock Earnings: Kezar Life Sciences Misses EPS for Q4 2023
investorplace.com - March 14 at 10:03 PM
businesswire.com logoKezar Life Sciences Reports Fourth Quarter and Year End 2023 Financial Results and Provides Business Update
businesswire.com - March 14 at 4:01 PM
finanznachrichten.de logoEverest Medicines' Partner Calliditas Therapeutics Announces U.S. FDA Grants an Additional Seven-Year Orphan Drug Exclusivity Period for Nefecon
finanznachrichten.de - March 12 at 3:21 PM
finance.yahoo.com logoKezar Life Sciences, Inc. (KZR)
finance.yahoo.com - March 3 at 2:56 PM
marketbeat.com logoAcadian Asset Management LLC Has $988,000 Position in Kezar Life Sciences, Inc. (NASDAQ:KZR)
marketbeat.com - February 29 at 5:46 AM
finance.yahoo.com logoKezar Life Sciences to Participate in the TD Cowen 44th Annual Health Care Conference
finance.yahoo.com - February 28 at 5:39 PM
markets.businessinsider.com logoBuy Rating Affirmed for Kezar Life Sciences Amidst Progress in Lupus Nephritis Treatment and Expansion into Chinese Market
markets.businessinsider.com - February 27 at 4:36 PM
businesswire.com logoEverest Medicines and Kezar Life Sciences Receive IND Approval from China NMPA for PALIZADE Trial in Lupus Nephritis
businesswire.com - February 26 at 6:30 PM
prnewswire.com logoEverest Medicines and Kezar Life Sciences Receive IND Approval from China NMPA for PALIZADE Trial in Lupus Nephritis
prnewswire.com - February 26 at 6:10 PM
investorplace.com logo3 Top Penny Stocks for 5,000% Upside in 2024 and Beyond
investorplace.com - February 25 at 2:12 PM
benzinga.com logoKezar Life Sciences Stock (NASDAQ:KZR) Dividends: History, Yield and Dates
benzinga.com - February 22 at 12:59 AM
thestreet.com logoKezar Life Sciences Inc.
thestreet.com - February 19 at 7:24 PM
finance.yahoo.com logo3 Penny Stocks Poised for an Unbelievable 1,000% Jump
finance.yahoo.com - February 10 at 9:24 AM
morningstar.com logoKezar Life Sciences Inc KZR
morningstar.com - January 31 at 6:24 PM
finance.yahoo.com logoKZR Jan 2025 17.500 call
finance.yahoo.com - January 18 at 5:16 PM
finance.yahoo.com logoBull Run Bonanza: Top 3 Penny Stocks Primed for Explosive Growth
finance.yahoo.com - December 26 at 8:31 AM
msn.com logoEverest inches towards clinical studies for renal disease drug in China
msn.com - December 5 at 2:26 AM
markets.businessinsider.com logoBuy Rating Affirmed: Kezar Life Sciences’ Promising Trials and Strong Financials
markets.businessinsider.com - November 27 at 9:42 PM
markets.businessinsider.com logoAnalyst Expectations for Kezar Life Sciences's Future
markets.businessinsider.com - November 27 at 9:45 AM
finance.yahoo.com logoKezar Life Sciences to Present at the 6th Annual Evercore ISI HealthCONx Conference
finance.yahoo.com - November 21 at 8:37 PM
benzinga.com logoKezar Life Sciences Stock (NASDAQ:KZR), Analyst Ratings, Price Targets, Predictions
benzinga.com - November 14 at 7:39 PM
finance.yahoo.com logoKezar Life Sciences Reports Third Quarter 2023 Financial Results and Provides Business Update
finance.yahoo.com - November 13 at 4:38 PM
finance.yahoo.com logo12 Best Penny Stocks to Buy Under $1
finance.yahoo.com - October 23 at 1:12 PM
nasdaq.com logoHC Wainwright & Co. Reiterates Kezar Life Sciences (KZR) Buy Recommendation
nasdaq.com - October 13 at 5:54 AM
markets.businessinsider.com logoRestructuring and Clinical Progress Bolster Kezar Life Sciences’ Buy Rating: An Analysis
markets.businessinsider.com - October 12 at 5:15 PM
msn.com logoJonesTrading Downgrades Kezar Life Sciences (KZR)
msn.com - October 5 at 6:48 PM
seekingalpha.com logoKezar Life Sciences names new CEO, says to cut workforce by about 41%
seekingalpha.com - October 5 at 12:32 AM
marketbeat.com logo
marketbeat.com - October 3 at 4:09 PM
markets.businessinsider.com logoKezar Life Sciences’ Potential High Returns and Extended Lifespan through Everest Medicines Collaboration: A Buy Rating Analysis
markets.businessinsider.com - September 25 at 9:06 AM
msn.com logoKezar and Everest enter lupus nephritis therapy development deal
msn.com - September 21 at 9:25 AM
marketwatch.com logoKezar Life Sciences Shares Rise After Deal With Everest Medicines
marketwatch.com - September 20 at 10:41 PM
businesswire.com logoKezar Life Sciences and Everest Medicines Enter into an Agreement to Develop and Commercialize Zetomipzomib for Lupus Nephritis and other Potential Indications in Greater China ...
businesswire.com - September 20 at 10:41 PM
finance.yahoo.com logoKezar Life Sciences and Everest Medicines Enter into an Agreement to Develop and Commercialize Zetomipzomib for Lupus Nephritis and other Potential Indications in Greater China, South Korea and Southeast Asia
finance.yahoo.com - September 20 at 10:41 PM
marketbeat.com logoKezar Life Sciences, Inc. (NASDAQ:KZR) Shares Acquired by Russell Investments Group Ltd.
marketbeat.com - September 1 at 4:21 AM
marketbeat.com logoConnor Clark & Lunn Investment Management Ltd. Lowers Holdings in Kezar Life Sciences, Inc. (NASDAQ:KZR)
marketbeat.com - August 28 at 5:27 AM
marketbeat.com logoCHI Advisors LLC Has $2.16 Million Stock Holdings in Kezar Life Sciences, Inc. (NASDAQ:KZR)
marketbeat.com - August 25 at 3:18 PM
marketbeat.com logoShort Interest in Kezar Life Sciences, Inc. (NASDAQ:KZR) Declines By 6.0%
marketbeat.com - August 17 at 1:39 AM
marketbeat.com logoBarclays PLC Grows Holdings in Kezar Life Sciences, Inc. (NASDAQ:KZR)
marketbeat.com - August 16 at 4:37 AM
247wallst.com logoWells Fargo Downgrades Kezar Life Sciences
247wallst.com - August 14 at 3:22 PM
msn.com logoWells Fargo Downgrades Kezar Life Sciences (KZR)
msn.com - August 12 at 10:33 AM
marketwatch.com logoKezar Life Sciences Down 25% After 2Q Results, Drug Updates
marketwatch.com - August 11 at 7:33 PM
marketbeat.com logoKezar Life Sciences (NASDAQ:KZR) Price Target Lowered to $18.00 at HC Wainwright
marketbeat.com - August 11 at 8:00 AM
Get Kezar Life Sciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for KZR and its competitors with MarketBeat's FREE daily newsletter.

New crypto project uncovers 2,050% in 65 days (Ad)

During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.

Just click here to sign up and be among the first to get it.

KZR Media Mentions By Week

KZR Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

KZR
News Sentiment
▼
0.31

0.53
▲
Average
Medical
News Sentiment

KZR News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

KZR Articles
This Week
▼
3

1
▲
KZR Articles
Average Week

Get Kezar Life Sciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for KZR and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

Related Companies:
Headlines Tools:
This page (NASDAQ:KZR) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners
Healthcare Takes A Big Step Forward With The Help Of AI
The Bull Report
The Best AI Stock to Own in the World Today is Trading for Just $25
Banyan Hill Publishing
Biden’s $374B Giveaway Into This Sector
DTI
Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS
Paradigm Press
He Is Giving Away Bitcoin
Crypto Swap Profits
The #1 Crypto for 2024
InvestorPlace
How Biden has already won 2024
Porter & Company
Urgent alert: open this for a huge profit potential
Timothy Sykes